Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma

Gastrointestinal Cancer

Hepatotoxicity from Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation

Hepatology.

Peeraphatdit TB, Wang J, Odenwald MA, Hu S, Hart J, Charlton MR

doi: 10.1002/hep.31227.

Hepatology

Targeted and Immune-based Therapies for Hepatocellular Carcinoma

Gastroenterology.

Greten TF, Lai CW, Li G, Staveley-O'Carroll KF

doi: 10.1053/j.gastro.

COMMENTED

Inflammatory Bowel Disease

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study

doi: 10.1186/s40425-018-0461-4.

Gallbladder and Biliary Diseases

Liquid biopsy in the clinical management of hepatocellular carcinoma

Gut

von Felden J, Garcia-Lezana T, Schulze K, Losic B, Villanueva A

doi: 10.1136/gutjnl-2019-320282

Inflammatory Bowel Disease

IFNγ-producing CD8⁺ tissue resident memory T cells are a targetable hallmark of immune checkpoint inhibitor-colitis

Gastroenterology

Sasson SC, Slevin SM, Cheung VT, Nassiri I, Olsson-Brown A, Fryer E, Ferreira RC, Trzupek D, Gupta T, Al-Hillawi L, Issaias ML, Easton A, Campo L, FitzPatrick ME, Adams J, Chitnis M, Protheroe A, Tuthill M, Coupe N, Simmons A, Payne M, Middleton MR, Travis SP, Oxford IBD Cohort Investigators., Fairfax BP, Klenerman P, Brain O

doi: 10.1053/j.gastro.2021.06.025

Hepatology

Introduction to the Liver Imaging Reporting and Data System (LI-RADS) for hepatocellular carcinoma

Clin Gastroenterol Hepatol.

Tang A, Singal AG, Mitchell DG, Hecht EM, Fowler KJ, Kulik L, Parikh ND, Kono Y, Sirlin CB

doi: 10.1016/j.cgh.

Gastrointestinal CancerFurther Publications

Systemic treatment of hepatocellular carcinoma. An EASL position paper

J Hepatol

Bruix J, Chan SL, Galle PR, Rimassa L, Sangro B

doi: 10.1016/j.jhep.2021.07.004

HepatitisHepatology

Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study

J Hepatol.

Romano A, Angeli P, Piovesan S, Noventa F, Anastassopoulos G, Chemello L, Cavalletto L, Gambato M, Russo FP, Burra P, Vincenzi V, Scotton PG, Panese S, Tempesta D, Bertin T, Carrara M, Carlotto A, Capra F, Carolo G, Scroccaro G, Alberti A

doi: 10.1016/j.jhep.2018.03.009.

Gastrointestinal Cancer

Pseudoprogression in patients treated with immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer

Eur J Cancer

Colle R, Radzik A, Cohen R, Pellat A, Lopez-Tabada D, Cachanado M, Duval A, Svrcek M, Menu Y, André T

doi: 10.1016/j.ejca.2020.11.009

Related content